Announcements Trials
Browse Landscape

Phase

Phase 2 159Phase 3 30Phase 1/2 16Phase 1 10Phase NA 7Phase 2/3 3Phase EARLY_PHASE1 2Phase 4 2

Status

Completed 14Recruiting 5Terminated 4Not yet recruiting 3Withdrawn 2Unknown 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 1Colorectal Neoplasms 1

Interventions

Metformin 16Cyclophosphamide 16Drug Therapy 14Dexamethasone 14Cisplatin 13Cytarabine 11Gemcitabine 10Radiotherapy 9Oxaliplatin 9Carboplatin 9Vincristine 8Paclitaxel 8Idarubicin 8Etoposide 8Docetaxel 8ulipristal acetate 7icotinib 7Sodium Chloride 7Methotrexate 7Fluorouracil 7Dexmedetomidine 7entecavir 6Thalidomide 6Surgical Procedures, Operative 6Sorafenib 6Pemetrexed 6Leuprolide 6Granulocyte Colony-Stimulating Factor 6Epirubicin 6Doxorubicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Bevacizumab × Clear all
NCT06269445 2024-02-21

The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer

Sir Run Run Shaw Hospital

Phase 4 Unknown
20 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01706120 2023-03-24

MITO16/MANGO-2

National Cancer Institute, Naples

Phase 4 Unknown
400 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡